FDA Recalls GE’s Aisys and Avance Anesthesia Systems

The U.S. Food and Drug Administration has issued a Class I recall of GE Healthcare’s Aisys and Avance Anesthesia systems, due to a defect in control board wiring harnesses, which can cause the machine to unexpectedly shut down, terminating ventilation, anesthetic delivery and potentially patient monitoring, according to an FDA news release.

Advertisement

The affected devices were distributed between Oct. 9 and Oct. 29, 2009. They include the following lot numbers:

  • Aisys (model no. 1011-9000-000) — ANAN00814, ANAN00815, ANAN00825, ANAN00830, ANAN00831, ANAN00831, ANAN00832, ANAN00833, ANAN00834, ANAN00835, ANAN00836, ANAN00837, ANAN00838, ANAN00839, ANAN00873
  • Avance (model no. 1009-9002-000) — ANBN01180, ANBN01187, ANBN01200, ANBN01201, ANBN01211, ANBN01212, ANBN01213, ANBN01220, ANBN01223, ANBN01224, ANBN01250, ANBN01266, ANBN01284, ANBN01285, ANBN01286, ANBN01287, ANBN01288, ANBN01289

The Aisys and Avance systems are prescription devices used in healthcare settings under the supervision of a physician and are used to provide general inhalation anesthesia and ventilation support to a wide range of patients, according to the release.

Customers were notified by the FDA on March 12, 2010. Adverse events associated with the device may be reported to the FDA’s MedWatch program.

Read the FDA’s recall of GE’s Aisys and Avance Anesthesia systems.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.